Ulcerative colitis and celiac disease share some biological overlap, but the clinical link between them is weaker than many people assume. Both are immune-driven conditions that damage the intestinal lining, and they share over 200 genes in disease-associated regions of the genome. Yet when researchers look at whether having one condition actually raises your risk of developing the other, the picture gets complicated. The relationship depends on which direction you’re looking and how you measure it.
What the Prevalence Numbers Show
One of the clearest ways to test for a link is to screen people with ulcerative colitis for celiac disease and compare that rate to the general population. A study of 200 ulcerative colitis patients found celiac disease in just 1 of them (0.5%), which was not statistically different from the background rate in the general population (about 0.6% in that study’s control group). That finding suggests ulcerative colitis doesn’t meaningfully increase your odds of having celiac disease at the same time.
However, a broader estimate from a recent Canadian Medical Association guideline puts the prevalence of celiac disease among people with inflammatory bowel disease (which includes both ulcerative colitis and Crohn’s disease) at 2 to 4%, and describes the association as “bidirectional.” That higher range likely reflects pooled data across different study designs and populations, and it’s high enough that some clinical guidelines now list inflammatory bowel disease as a condition worth screening for celiac disease.
Genetic Overlap Is Real but Limited
At the DNA level, these two conditions share a surprising amount of territory. Genome-wide association studies have identified 43 risk regions for celiac disease and 244 for inflammatory bowel disease. Within those regions, 206 genes overlap among celiac disease, Crohn’s disease, and ulcerative colitis. That’s a substantial intersection, and it points to shared biological vulnerabilities rather than coincidence.
Many of those shared genes relate to how the immune system presents threats to the body and how the gut lining holds itself together. For example, both conditions involve genes in the HLA region, which controls how immune cells identify foreign proteins. Both also involve a gene called PTPN2, which normally keeps immune cells from overreacting. When that gene doesn’t work properly, the immune system is more likely to attack the body’s own tissues. Another shared signal involves NOTCH4, a gene that controls how cells in the intestinal lining develop and renew themselves.
Still, shared genetics doesn’t mean shared disease. A Mendelian randomization study, which uses genetic data to test for cause-and-effect relationships, found no significant genetic correlation between ulcerative colitis and celiac disease in either direction. The odds ratio was essentially 1.0, meaning the genetic variants that predispose someone to one condition don’t appear to drive risk for the other. This stood in contrast to Crohn’s disease, which did show a genetic link to celiac disease risk.
Both Diseases Damage the Gut Barrier
One reason these conditions get grouped together is that both involve a breakdown of the intestinal barrier, the tightly sealed layer of cells that separates what’s inside your gut from the rest of your body. In celiac disease, this barrier defect is one of the best-understood steps in how the disease develops. Gluten triggers changes in the proteins that seal intestinal cells together, allowing partially digested food particles and immune-activating molecules to slip through. Specifically, the gut loses protective sealing proteins and gains more of a pore-forming protein that lets water and molecules leak between cells.
In ulcerative colitis, the barrier breaks down too, but the mechanism is different and the cause-and-effect question is still unresolved. Studies using tissue from ulcerative colitis patients show a roughly 50% drop in the electrical resistance of the colon wall, a direct measure of how well the barrier is sealing. The number of structural strands holding cells together is reduced. Whether this leakiness causes the inflammation or results from it remains one of the open questions in the field.
How the Two Conditions Feel Different
Despite their biological overlap, ulcerative colitis and celiac disease usually present quite differently. Bloody, mucus-containing diarrhea is the near-universal hallmark of ulcerative colitis. It’s hard to miss and tends to bring people to a doctor quickly. Celiac disease in adults, by contrast, is often subtle. It can show up as intermittent diarrhea, vague abdominal pain, bloating, or even constipation. Many people with celiac disease go years without a diagnosis because the symptoms mimic common digestive complaints.
The diagnostic markers are also distinct. Celiac disease is identified through specific antibodies in the blood, most reliably anti-tissue transglutaminase antibodies, followed by a biopsy of the small intestine. Ulcerative colitis is diagnosed primarily through colonoscopy and tissue biopsy of the colon, and its characteristic blood marker is a type of antibody directed against components of white blood cells. These differences mean that if you have one condition and develop new or changing symptoms, testing for the other involves a completely separate set of tools.
A Gluten-Free Diet Does Not Treat UC
Because celiac disease is managed entirely through a gluten-free diet, it’s natural to wonder whether removing gluten might also help ulcerative colitis. A randomized, placebo-controlled trial tested exactly this in patients with mild to moderate ulcerative colitis who did not have celiac disease. The results were clear: the gluten-free diet produced no significant improvement in inflammatory markers, disease severity scores, or quality of life compared to the control group. A marker of intestinal inflammation called fecal calprotectin actually trended upward in both groups.
This matters because adopting a gluten-free diet is a significant lifestyle change, and doing so without evidence of celiac disease is unlikely to help ulcerative colitis on its own. If you have UC and suspect you also have celiac disease, the right step is blood testing for celiac-specific antibodies, not empirically cutting out gluten, which can actually interfere with accurate testing if done beforehand.
Should You Be Screened?
Current guidelines list inflammatory bowel disease as a condition that warrants consideration for celiac screening, particularly if you have symptoms that don’t fully fit your UC diagnosis. Persistent symptoms despite well-controlled inflammation, unexplained iron deficiency, or weight loss that seems out of proportion to your disease activity could all be reasons to test. The screening itself is straightforward: a blood draw to check for anti-tissue transglutaminase antibodies, ideally while you’re still eating gluten.
The bottom line is that ulcerative colitis and celiac disease share meaningful biology, including hundreds of overlapping genetic signals and a common theme of barrier breakdown. But the clinical overlap is modest. Having one does not strongly predict having the other, and treatments don’t cross over. They are related conditions in the way that many autoimmune diseases are related: similar immune machinery going wrong in different ways, in different parts of the gut, with different triggers.